Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

1 result

  • Active substance : spironolactone
  • Language : Français
  • Topics : Mental disorders and behavioural conditions
Filter
Topic
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Medical equipement (1)
  • Diseases and conditions (1)
  • Plus ...
    • Mental disorders and behavioural conditions (1)
    • Plus ...
      • Eating and sleep disorders (1)
    • Respiratory tract diseases (1)
    • Plus ...
      • Respiration disorders (1)
    • Otorhinolaryngologic diseases (1)
    • Plus ...
      • Phayngeal diseases (1)
    • Dental and mouth diseases (1)
    • Plus ...
      • Mouth diseases (1)
    • Heart diseases (1)
    • Plus ...
      • Heart failure (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Opinions on products and services (1)
Fabricant
  • RESMED SAS FRANCE (1)
Langue
  • Français (1)
Substance active
  • spironolactone (1)
More filter Other Filter Icon
Search Export

Drugs, devices and medical acts - 1 result

  • AUTOSET CS - 29 june 2010 (2413) - Opinion

    Opinion on medical devices and other health products - Posted on 6/7/2010
    Download opinion
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
aWEGRU5kPL13BZHR